U.S., New Zealand Firms Join To Produce Animals For Biosimilars
This article was originally published in PharmAsia News
Executive Summary
A U.S. company has entered into an agreement with a New Zealand partner to develop animals capable of being used to produce biosimilar drugs. Under the plan, GTC Biotherapeutics of the United States and AgResearch of New Zealand will collaborate in producing biosimilars of existing products. The New Zealand government also is heavily involved in the project and offers its backing to research efforts. (Click here for more